Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Pre-Tax Income
-$20.1m
CAGR 3-Years
49%
CAGR 5-Years
20%
CAGR 10-Years
-3%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Pre-Tax Income
-CA$7.4m
CAGR 3-Years
-149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Pre-Tax Income
-$2.1m
CAGR 3-Years
57%
CAGR 5-Years
21%
CAGR 10-Years
13%
Repare Therapeutics Inc
NASDAQ:RPTX
Pre-Tax Income
-$103.2m
CAGR 3-Years
-24%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Pre-Tax Income
-CA$823.4k
CAGR 3-Years
52%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Pre-Tax Income
-CA$25.1m
CAGR 3-Years
-44%
CAGR 5-Years
-53%
CAGR 10-Years
-8%

See Also

What is Aurinia Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-20.1m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Pre-Tax Income amounts to -20.1m USD.

What is Aurinia Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-3%

Over the last year, the Pre-Tax Income growth was 74%. The average annual Pre-Tax Income growth rates for Aurinia Pharmaceuticals Inc have been 49% over the past three years , 20% over the past five years , and -3% over the past ten years .

Back to Top